Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT05361915 · SUSPENDED

Trial details

NCT number: NCT05361915
Sponsor: Sorrento Therapeutics, Inc.
Status: SUSPENDED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Prostate Cancer Metastatic

Start date: 2025-09-01
Primary completion: 2028-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.